Ledger.Open graph →
SEC Form D · filed August 17, 2016

New Haven Pharmaceuticals, Inc

Offering
$1.3M
Sold
$602K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NORTH HAVEN, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Harry H. Penner, Jr · North Haven, CTExec · DirectorDaniel H. Wagner · North Haven, CTDirectorLarry H. Dillaha · New Haven, CTDirectorChristopher H. Ecklund · North Haven, CTDirectorTheodore H. Stanley · Murray, UTDirectorWilliam H. Sessa · North Haven, CTDirectorPatrick H. Fourteau · New Haven, CTExec · DirectorHarry H. Penner, Jr · BRANFORD, CTExec · DirectorChristopher H. Ecklund · North Haven, CTDirectorTheodore H. Stanley · North Haven, CTDirectorWilliam H. Sessa · North Haven, CTDirectorDaniel H. Wagner · North Haven, CTDirectorLarry H. Dillaha · New Haven, CTDirectorPatrick H. Fourteau · New Haven, CTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗